Brown Advisory Inc. bought a new position in shares of NationalResearchCorp . (NYSE:NRC) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 68,900 shares of the company’s stock, valued at approximately $2,660,000.
Other hedge funds have also bought and sold shares of the company. Royal Bank of Canada purchased a new stake in NationalResearchCorp . during the first quarter worth approximately $185,000. Credit Suisse AG purchased a new stake in NationalResearchCorp . during the third quarter worth approximately $202,000. American International Group Inc. purchased a new stake in NationalResearchCorp . during the third quarter worth approximately $283,000. Rhumbline Advisers purchased a new stake in NationalResearchCorp . during the third quarter worth approximately $366,000. Finally, Alliancebernstein L.P. purchased a new stake in NationalResearchCorp . during the third quarter worth approximately $501,000.
In other NationalResearchCorp . news, major shareholder K/I/E/Trust Under Agreement 3/ sold 2,640 shares of NationalResearchCorp . stock in a transaction that occurred on Wednesday, November 28th. The stock was sold at an average price of $40.00, for a total transaction of $105,600.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Kevin R. Karas sold 4,800 shares of NationalResearchCorp . stock in a transaction that occurred on Wednesday, September 19th. The stock was sold at an average price of $39.53, for a total value of $189,744.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 11,064 shares of company stock worth $440,304.
NRC stock opened at $38.89 on Friday. NationalResearchCorp . has a fifty-two week low of $26.35 and a fifty-two week high of $42.85.
NationalResearchCorp . (NYSE:NRC) last posted its earnings results on Tuesday, November 6th. The company reported $0.27 earnings per share for the quarter. The business had revenue of $30.01 million for the quarter.
About NationalResearchCorp .
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience, satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.
See Also: Derivative
Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NationalResearchCorp . (NYSE:NRC).
Receive News & Ratings for NationalResearchCorp . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NationalResearchCorp . and related companies with MarketBeat.com's FREE daily email newsletter.